These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

625 related articles for article (PubMed ID: 33493136)

  • 21. Comprehensive analysis of N6-methyladenosine -related long non-coding RNAs and immune cell infiltration in hepatocellular carcinoma.
    Yu ZL; Zhu ZM
    Bioengineered; 2021 Dec; 12(1):1708-1724. PubMed ID: 33955330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. m
    Wu Y; Yang X; Chen Z; Tian L; Jiang G; Chen F; Li J; An P; Lu L; Luo N; Du J; Shan H; Liu H; Wang H
    Mol Cancer; 2019 Apr; 18(1):87. PubMed ID: 30979372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
    Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS
    BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcriptome profiling and co-expression network analysis of lncRNAs and mRNAs in colorectal cancer by RNA sequencing.
    Li M; Guo D; Chen X; Lu X; Huang X; Wu Y
    BMC Cancer; 2022 Jul; 22(1):780. PubMed ID: 35842644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. lncRNAs AC156455.1 and AC104532.2 as Biomarkers for Diagnosis and Prognosis in Colorectal Cancer.
    Kuang F; Luo D; Zhou M; Du J; Yang J
    Dis Markers; 2022; 2022():4872001. PubMed ID: 36277972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long noncoding RNA GAS5 inhibits progression of colorectal cancer by interacting with and triggering YAP phosphorylation and degradation and is negatively regulated by the m
    Ni W; Yao S; Zhou Y; Liu Y; Huang P; Zhou A; Liu J; Che L; Li J
    Mol Cancer; 2019 Oct; 18(1):143. PubMed ID: 31619268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A ten N6-methyladenosine-related long non-coding RNAs signature predicts prognosis of triple-negative breast cancer.
    Wu J; Cai Y; Zhao G; Li M
    J Clin Lab Anal; 2021 Jun; 35(6):e23779. PubMed ID: 33934391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Construction of ceRNA Coexpression Network and Screening of Molecular Targets in Colorectal Cancer.
    Hui Z; Zhanwei W; Xi Y; Jin L; Jing Z; Shuwen H
    Dis Markers; 2020; 2020():2860582. PubMed ID: 32377269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N6-Methyladenosine-Related LncRNAs Are Potential Remodeling Indicators in the Tumor Microenvironment and Prognostic Markers in Osteosarcoma.
    Wu Z; Zhang X; Chen D; Li Z; Wu X; Wang J; Deng Y
    Front Immunol; 2021; 12():806189. PubMed ID: 35095893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive analysis of differentially expressed profiles of lncRNAs and construction of miR-133b mediated ceRNA network in colorectal cancer.
    Wu H; Wu R; Chen M; Li D; Dai J; Zhang Y; Gao K; Yu J; Hu G; Guo Y; Lin C; Li X
    Oncotarget; 2017 Mar; 8(13):21095-21105. PubMed ID: 28177879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Research progress of N6-methyladenosine in colorectal cancer: A review.
    Lin Y; Shi H; Wu L; Ge L; Ma Z
    Medicine (Baltimore); 2023 Nov; 102(47):e36394. PubMed ID: 38013272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of N6-methyladenosine-related lncRNAs in the tumor immune microenvironment and their prognostic role in pancreatic cancer.
    Liu Y; Wang T; Fang Z; Kong J; Liu J
    J Cancer Res Clin Oncol; 2022 Jul; 148(7):1613-1626. PubMed ID: 35314871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and validation of a novel N6-methyladenosine (m6A)-related multi- long non-coding RNA (lncRNA) prognostic signature in pancreatic adenocarcinoma.
    Yuan Q; Ren J; Li L; Li S; Xiang K; Shang D
    Bioengineered; 2021 Dec; 12(1):2432-2448. PubMed ID: 34233576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comprehensive ceRNA network analysis and experimental studies identify an IGF2-AS/miR-150/IGF2 regulatory axis in colorectal cancer.
    Liu B; Liu Y; Zhou M; Yao S; Bian Z; Liu D; Fei B; Yin Y; Huang Z
    Pathol Res Pract; 2020 Oct; 216(10):153104. PubMed ID: 32853944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of the 3-lncRNA Signature as a Prognostic Biomarker for Colorectal Cancer.
    Liu S; Cao Q; An G; Yan B; Lei L
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33302562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RNA sequencing and bioinformatics analysis of the long noncoding RNA-mRNA network in colorectal cancer.
    Zhang Z; Jia H; Gu T; Hu Q; Yu J; Zang D; Song N; Wang H
    J Cell Biochem; 2018 Dec; 119(12):9957-9966. PubMed ID: 30145796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of key lncRNAs in colorectal cancer progression based on associated protein-protein interaction analysis.
    Zhu H; Yu J; Zhu H; Guo Y; Feng S
    World J Surg Oncol; 2017 Aug; 15(1):153. PubMed ID: 28797257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST.
    Yang X; Zhang S; He C; Xue P; Zhang L; He Z; Zang L; Feng B; Sun J; Zheng M
    Mol Cancer; 2020 Feb; 19(1):46. PubMed ID: 32111213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and development of long non-coding RNA-associated regulatory network in colorectal cancer.
    Pan H; Pan J; Song S; Ji L; Lv H; Yang Z
    J Cell Mol Med; 2019 Aug; 23(8):5200-5210. PubMed ID: 31144439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive analysis of lncRNA-associated ceRNA network in colorectal cancer.
    Yuan W; Li X; Liu L; Wei C; Sun D; Peng S; Jiang L
    Biochem Biophys Res Commun; 2019 Jan; 508(2):374-379. PubMed ID: 30503344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.